Last Close
15.93 £
Jul 6, 26
Market Cap
9.3 B £
Q1 2026 (TTM)
52-Week Range
%-29.5
%74.9
-0.62
-0.59
%-45.7
-%55.5
1M
+7.9%
3M
-14.8%
6M
-8.7%
YTD
-8.9%
1Y
-35.1%
3Y
+629.1%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in GBP (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
SMMT last closed at 15.93 £ (Jul 6, 26). Price data is refreshed after every trading day.
Summit Therapeutics PLC (SMMT) has a market capitalization of approximately 9.3 B £ as of the latest reported period.
Key peers of Summit Therapeutics PLC include CSL Ltd, TELIX Pharmaceuticals Ltd, Mesoblast Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.